Data / Form D filings / Stratos Genomics Inc.
Stratos Genomics Inc.: Form D filings
Stratos Genomics Inc., a biotechnology company in Seattle, WA, filed 8 Form D notices with the SEC between 2010 and 2018. The latest, on January 9, 2018, reports $20.2 million sold of a $20.2 million offering to 4 investors.
Find out what Stratos Genomics Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- WORLD TRADE CENTER EAST, 2211 ELLIOTT AVENUE, Seattle, WA, 98121
- Phone
- (206) 448-1388
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Washington
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1501187
The full lists. Form D filings in Washington: 1,095 rows, $54.75, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jan 9, 2018 | New notice | $20,156,451 | $20,156,451 | $0 | 4 | Nov 28, 2017 | sec.gov |
| Jun 7, 2016 | Amendment | $4,520,502 | $4,520,502 | $0 | 19 | Jul 30, 2010 | sec.gov |
| Jun 17, 2015 | Amendment | $29,999,975 | $29,999,975 | $0 | 2 | Apr 30, 2014 | sec.gov |
| May 13, 2014 | New notice | $16,306,996 | $9,999,999 | $6,306,997 | 1 | Apr 30, 2014 | sec.gov |
| Sep 6, 2013 | New notice | $3,000,000 | $2,000,000 | $1,000,000 | 1 | Sep 4, 2013 | sec.gov |
| Oct 16, 2012 | New notice | $4,000,000 | $2,000,000 | $2,000,000 | 1 | Oct 3, 2012 | sec.gov |
| May 26, 2011 | New notice | $2,500,000 | $210,720 | $2,289,280 | 5 | May 12, 2011 | sec.gov |
| Sep 14, 2010 | New notice | $3,968,291 | $3,968,291 | $0 | 19 | Jul 30, 2010 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Stephen Rose | Director | |
| Heiner Dreismann | Director | |
| Mark Kokoris | Executive Officer, Director | |
| Harold Kawaguchi | Director | |
| Robert McRuer | Director | |
| Lee Huntsman | Director |
Other biotechnology companies in Washington that filed recently
- Key Proteo, Inc. $2.3 million · Oct 23, 2026
- Inmedix, Inc. $4 million · Oct 22, 2026
- Q-Immune, Inc. $25,000 · Sep 28, 2026
- Hexamer Therapeutics, Inc $500,000 · Sep 15, 2026
- MalarVx, Inc. $125,000 · Aug 25, 2026
- Strella Biotechnology, Inc. $1.8 million · Aug 14, 2026
Every Form D from the week of Jan 8, 2018 · All recent filings in Washington · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Stratos Genomics Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.